Early stage and long term treatment of multiple sclerosis with interferon-β
Angela Applebee, Hillel PanitchDepartment of Neurology, University of Vermont College of Medicine, and Neurology Service, Fletcher Allen Health Care, Burlington, VT, USAAbstract: Multiple sclerosis (MS) affects young adults during the most productive years of their lives, and until recently many neu...
Saved in:
Main Authors: | Angela Applebee, Hillel Panitch |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/092d155f8e394cb09f79438b176a78f3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
by: Castrop F, et al.
Published: (2013) -
Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis
by: Francesco Manfredonia, et al.
Published: (2008) -
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
by: Damiano Paolicelli, et al.
Published: (2009) -
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
by: Slobodan M Jankovic
Published: (2010) -
PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
by: Reuss R
Published: (2013)